207 related articles for article (PubMed ID: 18344999)
21. Cyclin K/CPR4 inhibits primate lentiviral replication by inactivating Tat/positive transcription elongation factor b-dependent long terminal repeat transcription.
Urano E; Shimizu S; Futahashi Y; Hamatake M; Morikawa Y; Takahashi N; Fukazawa H; Yamamoto N; Komano J
AIDS; 2008 May; 22(9):1081-3. PubMed ID: 18520353
[TBL] [Abstract][Full Text] [Related]
22. Mapping the architecture of the HIV-1 Tat circuit: A decision-making circuit that lacks bistability and exploits stochastic noise.
Razooky BS; Weinberger LS
Methods; 2011 Jan; 53(1):68-77. PubMed ID: 21167940
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of human immunodeficiency virus type 1 transcription by N-aminoimidazole derivatives.
Stevens M; Balzarini J; Lagoja IM; Noppen B; François K; Van Aerschot A; Herdewijn P; De Clercq E; Pannecouque C
Virology; 2007 Aug; 365(1):220-37. PubMed ID: 17459445
[TBL] [Abstract][Full Text] [Related]
24. Human immunodeficiency virus-1 Tat protein: immunological facets of a transcriptional activator.
Gupta S; Mitra D
Indian J Biochem Biophys; 2007 Oct; 44(5):269-75. PubMed ID: 18341200
[TBL] [Abstract][Full Text] [Related]
25. An HIV feedback resistor: auto-regulatory circuit deactivator and noise buffer.
Weinberger LS; Shenk T
PLoS Biol; 2007 Jan; 5(1):e9. PubMed ID: 17194214
[TBL] [Abstract][Full Text] [Related]
26. NF-kappaB-dependent control of HIV-1 transcription by the second coding exon of Tat in T cells.
Mahlknecht U; Dichamp I; Varin A; Van Lint C; Herbein G
J Leukoc Biol; 2008 Mar; 83(3):718-27. PubMed ID: 18070983
[TBL] [Abstract][Full Text] [Related]
27. Tat's seductive side.
Stevenson M
Nat Med; 2003 Feb; 9(2):163-4. PubMed ID: 12563332
[No Abstract] [Full Text] [Related]
28. Probabilistic control of HIV latency and transactivation by the Tat gene circuit.
Cao Y; Lei X; Ribeiro RM; Perelson AS; Liang J
Proc Natl Acad Sci U S A; 2018 Dec; 115(49):12453-12458. PubMed ID: 30455316
[TBL] [Abstract][Full Text] [Related]
29. Reactive oxygen species activate HIV long terminal repeat via post-translational control of NF-kappaB.
Pyo CW; Yang YL; Yoo NK; Choi SY
Biochem Biophys Res Commun; 2008 Nov; 376(1):180-5. PubMed ID: 18765232
[TBL] [Abstract][Full Text] [Related]
30. Hyperthermia stimulates HIV-1 replication.
Roesch F; Meziane O; Kula A; Nisole S; Porrot F; Anderson I; Mammano F; Fassati A; Marcello A; Benkirane M; Schwartz O
PLoS Pathog; 2012; 8(7):e1002792. PubMed ID: 22807676
[TBL] [Abstract][Full Text] [Related]
31. Engineering, cloning, and functional characterization of recombinant LIM mineralization protein-1 containing an N-terminal HIV-derived membrane transduction domain.
Sangadala S; Okada M; Liu Y; Viggeswarapu M; Titus L; Boden SD
Protein Expr Purif; 2009 Jun; 65(2):165-73. PubMed ID: 19284982
[TBL] [Abstract][Full Text] [Related]
32. Transcription of HIV: Tat and cellular chromatin.
Gatignol A
Adv Pharmacol; 2007; 55():137-59. PubMed ID: 17586314
[No Abstract] [Full Text] [Related]
33. Distinct promoter activation mechanisms modulate noise-driven HIV gene expression.
Chavali AK; Wong VC; Miller-Jensen K
Sci Rep; 2015 Dec; 5():17661. PubMed ID: 26666681
[TBL] [Abstract][Full Text] [Related]
34. Reciprocal transactivation between HIV-1 and other human viruses.
White MK; Gorrill TS; Khalili K
Virology; 2006 Aug; 352(1):1-13. PubMed ID: 16725168
[TBL] [Abstract][Full Text] [Related]
35. HIV-1 Tat dysregulation of lipopolysaccharide-induced cytokine responses: microbial interactions in HIV infection.
Yim HC; Li JC; Lau JS; Lau AS
AIDS; 2009 Jul; 23(12):1473-84. PubMed ID: 19622906
[TBL] [Abstract][Full Text] [Related]
36. The 73 kDa subunit of the CPSF complex binds to the HIV-1 LTR promoter and functions as a negative regulatory factor that is inhibited by the HIV-1 Tat protein.
de la Vega L; Sánchez-Duffhues G; Fresno M; Schmitz ML; Muñoz E; Calzado MA
J Mol Biol; 2007 Sep; 372(2):317-30. PubMed ID: 17669424
[TBL] [Abstract][Full Text] [Related]
37. 2-Phenylquinolones as inhibitors of the HIV-1 Tat-TAR interaction.
Gatto B; Tabarrini O; Massari S; Giaretta G; Sabatini S; Del Vecchio C; Parolin C; Fravolini A; Palumbo M; Cecchetti V
ChemMedChem; 2009 Jun; 4(6):935-8. PubMed ID: 19283692
[TBL] [Abstract][Full Text] [Related]
38. Design, synthesis, and biological evaluation of novel quinoline derivatives as HIV-1 Tat-TAR interaction inhibitors.
Chen S; Chen R; He M; Pang R; Tan Z; Yang M
Bioorg Med Chem; 2009 Mar; 17(5):1948-56. PubMed ID: 19217787
[TBL] [Abstract][Full Text] [Related]
39. Novel piperidinylpyrimidine derivatives as inhibitors of HIV-1 LTR activation.
Fujiwara N; Nakajima T; Ueda Y; Fujita H; Kawakami H
Bioorg Med Chem; 2008 Nov; 16(22):9804-16. PubMed ID: 18926711
[TBL] [Abstract][Full Text] [Related]
40. Tat-SIRT1 tango.
Blazek D; Peterlin BM
Mol Cell; 2008 Mar; 29(5):539-40. PubMed ID: 18342601
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
